AI assistant
Sending…
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2014
Jun 25, 2014
10216_dirs_2014-06-24_91ee4a60-6ddc-47e5-8c00-d406209c47f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-06-24
Reporting Person: Applied Physics & Chemistry Laboratories, Inc. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7631594 | Direct |
More from Amphastar Pharmaceuticals, Inc.
Investor Presentation
2026
May 14
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
May 7
Investor Presentation
2026
Apr 14
Annual Report
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17